KALY Bullish Candlestick Pattern Confirms Short Squeeze Potential With 400% To 1000% ROI Potential - Watch For Imminent Rever...
July 11 2019 - 10:06AM
InvestorsHub NewsWire
KALY Bullish Candlestick Pattern
Confirms Short Squeeze Potential With 400% To 1000% ROI Potential -
Watch For Imminent Reversal
![](https://images.squarespace-cdn.com/content/v1/5652445be4b08f0af89331fc/1562852703604-EPU54VAYK2LCWU1GVPG5/ke17ZwdGBToddI8pDm48kIkO6DfV-5qhxu6AYJGq1IdZw-zPPgdn4jUwVcJE1ZvWEtT5uBSRWt4vQZAgTJucoTqqXjS3CfNDSuuf31e0tVGdP1drbJ2jYFZZBt3httLKPENaYSeHGZmM5H0HBc3woxur-lC0WofN0YB1wFg-ZW0/Screen+Shot+2019-07-11+at+8.42.44+AM.png?format=500w)
New York, NY -- July 11, 2019 --
InvestorsHub NewsWire -- via www.nextbigticker.com -- Kali-Extracts, Inc.
(USOTC:
KALY) was reported under a short squeeze alert yesterday and
today the KALY candlestick trading pattern confirms the short
squeeze potential. AmericanBulls.com has reported a BULLISH
DECENT BLOCK indicating that short sellers are fighting to hold
on.
AmericanBulls.com
on the BULLISH DECENT
BLOCK
“With three
black candlesticks, it looks as though bears rule over the market;
however there are signs of weaknesses. Firstly, the bodies get
shorter and shorter, showing that indecision is increasing.
Secondly, each day opens within the range of the previous day’s
body. Thirdly, the lower shadows are getting longer.
While the second and the third days are closing lower,
the distance between closes are getting shorter. This means that
the downtrend is losing strength and that short traders must be
cautious.”
KALY 400% to 1000%
ROI Potential
KALY has endured excessive short selling
with well over 50% of the recent trading volume coming from short
sales. FINRA has reported short selling as high as 83% of the
total volume. The candlestick pattern today indicates a coming
reversal is on the horizon and the short sellers having to cover
from excessive short sales could drive the KALY PPS even higher.
The company has announced
$15 million in CBD Extraction Contracts. KALY
reached almost $0.04 high late last year after acquiring the US
Patented Cannabis Extraction Process that is currently the center
of the company’s growing value. With KALY’s patented cannabis
pharmaceutical research now coming to light in combination with the
$15 million in CBD extraction contracts, the PPS is positioned to
shoot past the recent $0.04 high. With a short squeeze bonus, a
$0.10 PPS is not an unreasonable milestone.
![](https://images.squarespace-cdn.com/content/v1/5652445be4b08f0af89331fc/1562852683480-2GL2DCF3C558F4W2MSQE/ke17ZwdGBToddI8pDm48kKhoLdQssVkWSo-R351P7SlZw-zPPgdn4jUwVcJE1ZvWEtT5uBSRWt4vQZAgTJucoTqqXjS3CfNDSuuf31e0tVEP8csYTW9kazx9lDXM8ncS-ivo8wi4edARDmiXPVQahWQ6l2WM7tn7mqHTODzkmeM/Screen+Shot+2019-07-11+at+8.41.58+AM.png?format=500w)
In addition to the pharmaceutical research
and the $15 million in CBD extraction contracts, KALY is providing
CBD extracts for over $1 million worth of CBD infused water
produced by Puration, Inc. (USOTC:
PURA), and KALY has also introduced its own CBD infused gum,
Hemp4mula available on North American Cannabis Holdings (USOTC:
USMJ), Inc.’s website www.USMJ.com.
KALY Analyst
Report
Management engaged Goldman Small Cap
Research to conduct analyst coverage of the company and file an
initial analyst report: KALY Research
Report
Hemp, Inc. (HEMP)
is another heavily shorted stock making impressive operational
gains that stands to benefit from a potential short
squeeze.
Disclaimer:
NextBigTicker.com (NBT)is a third party
publisher and news dissemination service provider. NBT is NOT
affiliated in any manner with any company mentioned herein. NBT is
news dissemination solutions provider and are NOT a registered
broker/dealer/analyst/adviser, holds no investment licenses and may
NOT sell, offer to sell or offer to buy any security. NBT's
market updates, news alerts and corporate profiles are NOT a
solicitation or recommendation to buy, sell or hold securities. The
material in this release is intended to be strictly informational
and is NEVER to be construed or interpreted as research material.
All readers are strongly urged to perform research and due
diligence on their own and consult a licensed financial
professional before considering any level of investing in
stocks. All material included herein is republished content
and details which were previously disseminated by the companies
mentioned in this release or opinion of the writer. NBT is not
liable for any investment decisions by its readers or subscribers.
Investors are cautioned that they may lose all or a portion of
their investment when investing in stocks. NBT has not been
compensated for this release and HOLDS NO SHARES OF ANY
COMPANY NAMED IN THIS RELEASE.
Disclaimer/Safe
Harbor:
This news release contains forward-looking
statements within the meaning of the Securities Litigation Reform
Act. The statements reflect the Company's current views with
respect to future events that involve risks and uncertainties.
Among others, these risks include the expectation that any of the
companies mentioned herein will achieve significant sales, the
failure to meet schedule or performance requirements of the
companies' contracts, the companies' liquidity position, the
companies' ability to obtain new contracts, the emergence of
competitors with greater financial resources and the impact of
competitive pricing. In the light of these uncertainties, the
forward-looking events referred to in this release might not
occur.
Source: www.nextbigticker.com
Hemp (CE) (USOTC:HEMP)
Historical Stock Chart
From Jul 2024 to Aug 2024
Hemp (CE) (USOTC:HEMP)
Historical Stock Chart
From Aug 2023 to Aug 2024